|
|
Volumn 2008, Issue 3, 2008, Pages 293-302
|
|
Biomarkers and bioassays for cardiovascular diseases: Present and future
a
a
a
|
|
Author keywords
Aspirin; CK MB; Clopidogrel; Perfusion chamber; Troponin
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN;
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
CD40 LIGAND;
CELL PROTEIN;
CLOPIDOGREL;
CREATINE KINASE MB;
CYCLOOXYGENASE 1;
ENOXAPARIN;
FIBRINOGEN RECEPTOR ANTAGONIST;
INTERLEUKIN 6;
LEUKOTRIENE A4 HYDROLASE;
MYELOID RELATED PROTEIN 14;
MYOCYTE ENHANCING FACTOR 2A;
TRANSCRIPTOME;
TROPONIN;
ACUTE CORONARY SYNDROME;
BIOASSAY;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
EMERGENCY WARD;
HEART INFARCTION;
HUMAN;
PERCUTANEOUS CORONARY INTERVENTION;
PHARMACOGENOMICS;
PREDICTION;
REVIEW;
RISK ASSESSMENT;
SINGLE NUCLEOTIDE POLYMORPHISM;
THROMBOCYTE;
THROMBOSIS;
VALIDATION PROCESS;
|
|
EID: 44149122430
PISSN: None
EISSN: 11772719
Source Type: Journal
DOI: 10.1177/117727190800300001 Document Type: Review |
|
Times cited : (4)
|
|
References (92)
|
